Dermatomycoses
Recent clinical, regulatory, research and industry developments relating to this disease.
Dermatophyte infection: from fungal pathogenicity to host immune responses.
Diagnostic capacity for cutaneous fungal diseases in the African continent.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes5
- Dermatomycoses2
- Arthrodermataceae1
- HIV Infections1
- Malaria1
- Tinea1
Leading journals2
- Frontiers in immunology1
- International journal of dermatology1
Leading researchers8
- Ahmed SA1
- Badiane AS1
- Bah A1
- Ball M1
- Cá Z1
- Deng R1
- Denning DW1
- Dia MK1
Affiliations (unnormalised)6
- Beijing Key Laboratory of Molecular Diagnosis on Dermatoses1
- Center of Expertise in Mycology Radboudumc1
- Cheikh Anta Diop University of Dakar1
- Eduardo Mondlane University1
- Guinea Bissau National Health Center (CENAS)1
- Hôpital Universitaire JRB Antananarivo1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Reference
Authoritative identity, definition & identifiers.
Superficial infections of the skin or its appendages by any of various fungi.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.